Cargando…

Fingolimod mitigates synaptic deficits and psychosis‐like behavior in APP/PSEN1 mice

INTRODUCTION: Current treatments for psychosis in Alzheimer's disease (AD), a syndrome characterized by more rapid deterioration and reduced synaptic protein abundance relative to non‐psychotic AD, are inadequate. Fingolimod, a currently US Food and Drug Administration (FDA)–approved pharmacoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krivinko, Josh M., Erickson, Susan L., MacDonald, Matthew L., Garver, Megan E., Sweet, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395154/ https://www.ncbi.nlm.nih.gov/pubmed/36016832 http://dx.doi.org/10.1002/trc2.12324

Ejemplares similares

Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer Disease
por: Krivinko, J. M., et al.
Publicado: (2023)

Psychosis in Alzheimer's Disease Is Associated With Increased Excitatory Neuron Vulnerability and Post-transcriptional Mechanisms Altering Synaptic Protein Levels
por: DeChellis-Marks, Michael R., et al.
Publicado: (2022)

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
por: Hsu, Simon, et al.
Publicado: (2020)

Altered synaptic glutamate homeostasis contributes to cognitive decline in young APP/PSEN1 mice
por: Wilcox, J.M., et al.
Publicado: (2021)

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

Amyloid-β(1–43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
por: Perrone, Federica, et al.
Publicado: (2020)

From EST to structure models for functional inference of APP, BACE1, PSEN1, PSEN2 genes
por: Aathi, Muthusankar, et al.
Publicado: (2019)

APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
por: Xiao, Xuewen, et al.
Publicado: (2021)

Correction: Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

The associations of APP , PSEN1 , and PSEN2 genes with Alzheimer's disease: A large case–control study in Chinese population
por: Xiao, Xuewen, et al.
Publicado: (2022)

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
por: Lanoiselée, Hélène-Marie, et al.
Publicado: (2017)

Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease
por: Fan, Peihao, et al.
Publicado: (2023)

Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes
por: van Heusden, Fran C., et al.
Publicado: (2023)

Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease
por: Sassi, Celeste, et al.
Publicado: (2014)

Intravenous Delivery of Targeted Liposomes to Amyloid-β Pathology in APP/PSEN1 Transgenic Mice
por: Tanifum, Eric A., et al.
Publicado: (2012)

Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APP(Swe)/PSEN1(M146V) transgenic mice
por: Medawar, Evelyn, et al.
Publicado: (2018)

Identification of PSEN1 and APP Gene Mutations in Korean Patients with Early-Onset Alzheimer's Disease
por: Park, Hyun-Kyung, et al.
Publicado: (2008)

PSEN as an Educational Tool in Norway
por: Westvik, Tormod Schumacher
Publicado: (2017)

Effects of proton radiation on evoked and spontaneous neuronal activity in the hippocampus of APP/PSEN1 transgenic mice
por: Rudobeck, Emil, et al.
Publicado: (2014)

Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing
por: Inestrosa, N C, et al.
Publicado: (2011)

Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure
por: Geissbühler, Yvonne, et al.
Publicado: (2018)

Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro
por: Raut, Snehal, et al.
Publicado: (2021)

Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy
por: Li, Xu-Ying, et al.
Publicado: (2021)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice
por: Pascual-Lucas, Maria, et al.
Publicado: (2014)

Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer’s APP/PSEN1 mice by gene targeting of diabetes/Alzheimer’s-related Sorcs1
por: Knight, Elysse M., et al.
Publicado: (2016)

Persistent deficits in hippocampal synaptic plasticity accompany losses of hippocampus-dependent memory in a rodent model of psychosis
por: Wiescholleck, Valentina, et al.
Publicado: (2013)

Selective inhibitors of the PSEN1–gamma-secretase complex
por: Serneels, Lutgarde, et al.
Publicado: (2023)

APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal‐dominant Alzheimer's disease
por: Almkvist, Ove, et al.
Publicado: (2022)

Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1
por: Kurth, Vanessa, et al.
Publicado: (2023)

β - but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
por: Tamayev, Robert, et al.
Publicado: (2012)

β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
por: Tamayev, Robert, et al.
Publicado: (2012)

SIRT3 mediates hippocampal synaptic adaptations to intermittent fasting and ameliorates deficits in APP mutant mice
por: Liu, Yong, et al.
Publicado: (2019)

Ensemble stacking mitigates biases in inference of synaptic connectivity
por: Chambers, Brendan, et al.
Publicado: (2018)

The Arcuate Fasciculus Network and Verbal Deficits in Psychosis
por: Kenney, Joanne P.M., et al.
Publicado: (2017)

Human Presenilin-1 delivered by AAV9 rescues impaired γ-secretase activity, memory deficits, and neurodegeneration in Psen mutant mice
por: Montenegro, Paola, et al.
Publicado: (2023)

Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease
por: Yan, Hailong, et al.
Publicado: (2022)

Neurocognitive and Synaptic Potentiation Deficits Are Mitigated by Inhibition of HIF1a Signaling following Intermittent Hypoxia in Rodents
por: Carney, Rosalind S.E.
Publicado: (2020)

Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
por: Li, Siyao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bur2kjt56ej2e0nsnm82o4v4en